In this video, we put Shire‘s (LSE: SHP) deal with AbbVie (NYSE: ABBV) under the spotlight. For each share they held in Shire, investors will receive a cash consideration of £24.44 as well as 0.8960 new AbbVie shares. Here, two Fools look at whether investors should jump into either — or neither — of the pharmaceutical companies.
https://youtu.be/9FT7joTzQc0